中国伤残医学
中國傷殘醫學
중국상잔의학
CHINESE JOURNAL OF TRAUMA AND DISABILITY MEDICINE
2013年
11期
35-37
,共3页
邵军%李传方%高东升%李梅
邵軍%李傳方%高東升%李梅
소군%리전방%고동승%리매
对比剂肾病%危险因素%冠状动脉介入术
對比劑腎病%危險因素%冠狀動脈介入術
대비제신병%위험인소%관상동맥개입술
Contrast induced nephropathy%Risk factors%Percutaneous coronary intervention
目的:探讨冠状动脉介入术患者对比剂肾病的发病危险因素。方法:收集我院2010年03月~2011年10月期间住院的360例接受冠状动脉介入术患者的临床资料,以血肌酐为标准,测定介入治疗前后血清肌酐,分析发生对比剂肾病危险因素。结果:360例患者发生对比剂肾病28例,发生率7.71%(28/360),Logistic回归分析发现:吸烟支年、对比剂用量、遗传、高血压病、糖尿病、干预方法有统计学意义(P<0.05),即上述因素与CIN的发病密切相关。而性别、病变支数、LDL、尿酸与CIN的发病无明显相关关系。结论:CIN的发生危险因素包括吸烟支年、对比剂用量、遗传、高血压病、糖尿病、干预方法等。
目的:探討冠狀動脈介入術患者對比劑腎病的髮病危險因素。方法:收集我院2010年03月~2011年10月期間住院的360例接受冠狀動脈介入術患者的臨床資料,以血肌酐為標準,測定介入治療前後血清肌酐,分析髮生對比劑腎病危險因素。結果:360例患者髮生對比劑腎病28例,髮生率7.71%(28/360),Logistic迴歸分析髮現:吸煙支年、對比劑用量、遺傳、高血壓病、糖尿病、榦預方法有統計學意義(P<0.05),即上述因素與CIN的髮病密切相關。而性彆、病變支數、LDL、尿痠與CIN的髮病無明顯相關關繫。結論:CIN的髮生危險因素包括吸煙支年、對比劑用量、遺傳、高血壓病、糖尿病、榦預方法等。
목적:탐토관상동맥개입술환자대비제신병적발병위험인소。방법:수집아원2010년03월~2011년10월기간주원적360례접수관상동맥개입술환자적림상자료,이혈기항위표준,측정개입치료전후혈청기항,분석발생대비제신병위험인소。결과:360례환자발생대비제신병28례,발생솔7.71%(28/360),Logistic회귀분석발현:흡연지년、대비제용량、유전、고혈압병、당뇨병、간예방법유통계학의의(P<0.05),즉상술인소여CIN적발병밀절상관。이성별、병변지수、LDL、뇨산여CIN적발병무명현상관관계。결론:CIN적발생위험인소포괄흡연지년、대비제용량、유전、고혈압병、당뇨병、간예방법등。
Objective:Aim to investigate the risk factors of contrast -induced Nephropathy ( CIN) in the percutaneous coronary inter-vention(PCI).Methods:To collect the clinical data of 360 patients who underwent the PCI from March ,2010 to November, 2011, In or-der to serum creatinine as a standard , recorded the creatinine ( Cre) before and after treatment , and analyse the risk factors for occurrence of CIN.Results:The incidence of serum creatinine -based CIN was7.78%(28/360) in all .Risk factors Analysis:smoking variables of years, contrast agent dosage , genetic, hypertension, diabetes, intervention methods are statistically significant .But sex, lesion count, LDL, uric acid do not show statistically significant differences .Conclusion:The occurrence of CIN is closely associated with risk factors . such as smoking, contrast agent dosage , genetic, hypertension, diabetes, intervention methods and CIN .